EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Consensus Statement on Drug-Coated Balloons in Coronary Artery Disease from the Cardiovascular Intervention Association of Thailand

Pannipa Suwannasom iD, Korakoth Towashiraporn iD, Worawut Roongsangmanoon iD, Wiwat Kanjanarutjawiwat, Purich Surunchupakorn iD, Muenpetch Muenkaew, Ply Chichareon, Pisit Hutayanon, Anek Kanoksilp, Mann Chandavimol iD

Journal of Clinical Medicine · 23.10.2025 · 14 (21) · 7505

DOI: 10.3390/jcm14217505 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.10.2025. Verfasst von Pannipa Suwannasom und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cardiovascular Intervention Association of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-coated balloons (DCBs) have transformed percutaneous coronary intervention (PCI) by delivering antiproliferative drugs without leaving a permanent scaffold. DCB is initially indicated for in-stent restenosis (ISR) and now has expanded indication for treating small vessel disease and bifurcation lesions. However, there is a heterogeneity in the patient and lesion selection, lesion preparation techniques, and the optimal duration of dual antiplatelet therapy after DCB angioplasty. The Cardiovascular Intervention Association of Thailand (CIAT) developed a consensus statement on DCB use in coronary interventions.

Methods

The CIAT expert panel systematically reviewed randomized controlled trials, meta-analyses, and real-world studies evaluating DCB therapy. Procedural strategies, imaging guidance, physiologic assessment, and antiplatelet therapy protocols were appraised. The recommendations were developed and put to an online vote. Consensus was defined when the recommendation reached 80% of votes in support of “agree” or “neutral”.

Results

Clinical evidence demonstrates that DCBs achieve comparable outcomes to drug-eluting stents (DESs) in selected lesions while enabling shorter durations of dual antiplatelet therapy (DAPT), particularly beneficial for high-bleeding-risk patients. Optimal outcomes require meticulous lesion preparation, appropriate balloon sizing, and controlled vessel dissection. Intravascular imaging and physiologic assessment further refine procedural precision, while hybrid strategies combining DCBs and DESs address complex lesions and multivessel disease. The final document presents 15 consensus statements addressing indications, procedural techniques, imaging and physiologic guidance, and antiplatelet therapy recommendations.

Conclusions

DCB angioplasty can be an alternative or complement to therapeutic options to DESs across multiple clinical and anatomical scenarios. The CIAT consensus provided structured recommendations to support DCB therapy in contemporary practice.

Schlagwörter

Stichwörter der Autor:innen

coronary artery diseasedrug-coated balloondual antiplatelet therapyintravascular imagingsmall vessel disease

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Her Majesty Cardiac Center, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand.
  • King Prajadhipok Memorial Hospital, Chanthaburi 22000, Thailand.
  • Central Chest Institute of Thailand, Nonthaburi 11000, Thailand.
  • Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani 10120, Thailand.

ORCID-Profile: Pannipa Suwannasom, Korakoth Towashiraporn, Worawut Roongsangmanoon, Purich Surunchupakorn, Mann Chandavimol

Förderung

  • Cardiovascular Intervention Association of Thailand

Zitieren

APA

Suwannasom, P., Towashiraporn, K., Roongsangmanoon, W., Kanjanarutjawiwat, W., Surunchupakorn, P., Muenkaew, M., Chichareon, P., Hutayanon, P., Kanoksilp, A., & Chandavimol, M. (2025). Consensus Statement on Drug-Coated Balloons in Coronary Artery Disease from the Cardiovascular Intervention Association of Thailand. Journal of Clinical Medicine, 14(21), 7505. https://doi.org/10.3390/jcm14217505

Vancouver

Suwannasom P, Towashiraporn K, Roongsangmanoon W, Kanjanarutjawiwat W, Surunchupakorn P, Muenkaew M, et al. Consensus Statement on Drug-Coated Balloons in Coronary Artery Disease from the Cardiovascular Intervention Association of Thailand. Journal of Clinical Medicine. 2025;14(21):7505. doi:10.3390/jcm14217505

BibTeX
@article{Suwannasom2025,
  author = {Suwannasom, Pannipa and Towashiraporn, Korakoth and Roongsangmanoon, Worawut and Kanjanarutjawiwat, Wiwat and Surunchupakorn, Purich and Muenkaew, Muenpetch and Chichareon, Ply and Hutayanon, Pisit and Kanoksilp, Anek and Chandavimol, Mann},
  title = {Consensus Statement on Drug-Coated Balloons in Coronary Artery Disease from the Cardiovascular Intervention Association of Thailand},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {21},
  pages = {7505},
  doi = {10.3390/jcm14217505}
}
Kostenlos starten →